PUM1
OFFICE ACTION ISSUED POU1
06/25/2025
Back to search
Official data from USPTO
PHARMANEST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
06/26/2025
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
09/24/2019
Registration date
04/21/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2020
Last transaction
06/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/18/2011
First use in commerce
07/12/2019
Drawing code
4
Owner type
03
Owner location
PRINCETON, NJ
Examiner
BEVERLY, JOSETTE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PHARMANEST, INC.
MEDNEST
Representatives
PHARMANEST, INC.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Design and development of computer software; Providing temporary use of on-line non-downloadable cloud computing software for for use in electronic storage of digital imagesuse in the visualization of digital imagesuse in storage of electronic datain the field of digital pathology; Providing an interactive website featuring technology that allows users to collectarchivereviewanalyze and report on clinical research informationpre-clinical research informationdrug discovery and development information; Scientific research in the field of pathology; Medical and scientific research in the field of pharmaceuticalsbiopharmaceuticalsbiomarkersbioinformaticsclinical trialsphenotypingmedical diagnostics
Publications
History of USPTO decisions and trademark events.
13 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/25/2025
ES8R
TEAS SECTION 8 RECEIVED
04/21/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/21/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/15/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2020
PUBO
PUBLISHED FOR OPPOSITION
02/04/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/15/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2019
DOCK
ASSIGNED TO EXAMINER
12/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2019
NWAP
NEW APPLICATION ENTERED
09/27/2019
Continuous trademark protection
Get notified about every new filing that threatens PHARMANEST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.